STOCK TITAN

Accuray To Report First Quarter Fiscal 2021 Financial Results on October 29, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

SUNNYVALE, Calif., Oct. 15, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2021, ended September 30, 2020, after the market close on Thursday, October 29, 2020. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day.

The conference call dial-in numbers are (877) 270-2148 (USA) or (412) 902-6510 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is (877) 344-7529 (USA), or (412) 317-0088 (International), Conference ID: 10148905.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2021.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that are intended to make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.

Contacts:

Joe Diaz

Beth Kaplan

Investor Relations, Accuray

Public Relations Director, Accuray

(602) 717-7804

(408) 789-4426

jdiaz@accuray.com

bkaplan@accuray.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-to-report-first-quarter-fiscal-2021-financial-results-on-october-29-2020-301153538.html

SOURCE Accuray Incorporated

Accuray Incorporated

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Stock Data

167.60M
88.53M
3.58%
66.36%
5.31%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MADISON

About ARAY

accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.